Similar articles

• An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.

  Doyle LA, Ross DD, Ordonez JV, Yang W, Gao Y, Tong Y, Belani CP, Gutheil JC. Doyle LA, et al. Br J Cancer. 1995 Sep;72(3):535-42. doi: 10.1038/bjc.1995.370. Br J Cancer. 1995. PMID: 7669558 Free PMC article.
• In vitro models of multiple drug resistance.

  Greenberger LM, Cohen D, Horwitz SB. Greenberger LM, et al. Cancer Treat Res. 1994;73:69-106. doi: 10.1007/978-1-4615-2632-2_5. Cancer Treat Res. 1994. PMID: 7710911 Review. No abstract available.
• The genetic basis of resistance to cancer chemotherapy.

  Woodhouse JR, Ferry DR. Woodhouse JR, et al. Ann Med. 1995 Apr;27(2):157-67. doi: 10.3109/07853899509031953. Ann Med. 1995. PMID: 7632408 Review.
• Acute induction of adriamycin-resistance in human colon carcinoma HT-29 cells exposed to a sublethal dose of adriamycin.

  Tomida A, Naito M, Tsuruo T. Tomida A, et al. Jpn J Cancer Res. 1995 Feb;86(2):224-32. doi: 10.1111/j.1349-7006.1995.tb03043.x. Jpn J Cancer Res. 1995. PMID: 7730148 Free PMC article.
• Multidrug resistance: P-glycoprotein and its allies--the elusive foes.

  Chabner BA, Fojo A. Chabner BA, et al. J Natl Cancer Inst. 1989 Jun 21;81(12):910-3. doi: 10.1093/jnci/81.12.910. J Natl Cancer Inst. 1989. PMID: 2567356 Clinical Trial. No abstract available.